Zynex Stock

Zynex Current Assets

Delisted·Dec 23, 2025

The Current Assets of Zynex (ZYXI) as of Aug 25, 2026 is 75.18 M USD. In the previous year, Current Assets was 87.85 M USD — a change of -14.43% (lower).

Current Assets

75.18 MUSD

YoY

-14.43%

Last updated:

Current Assets of Zynex is 2026 75.18 M USD. Current Assets of Zynex was 2025 87.85 M USD. It decreases by -14.43% lower compared to the previous year.

The Zynex Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2017
8.39 M USD
Jan 1, 2018
14.33 M USD
Jan 1, 2019
22.53 M USD
Jan 1, 2020
62.99 M USD
Jan 1, 2021
82.66 M USD
Jan 1, 2022
69.60 M USD
Jan 1, 2023
87.85 M USD
Jan 1, 2024
75.18 M USD
The Zynex Current Assets history
YEARCurrent AssetsYoY
75.18 MUSD-14.43%
87.85 MUSD+26.24%
69.60 MUSD-15.80%
82.66 MUSD+31.23%
62.99 MUSD+179.53%
22.53 MUSD+57.21%
14.33 MUSD+70.92%
8.39 MUSD+147.08%
3.39 MUSD+23.87%
2.74 MUSD-52.33%
5.75 MUSD-57.98%
13.68 MUSD-35.90%
21.34 MUSD+18.12%
18.06 MUSD+44.25%
12.52 MUSD+39.50%
8.98 MUSD-3.71%
9.32 MUSD+43.93%
6.48 MUSD+159.90%
2.49 MUSD+118.89%
1.14 MUSD+108.97%
544,853.00USD+47.26%
370,000.00USD
0.00USD
0.00USD-100.00%
26,553.00USD+21,664.75%
122.00USD0.00%
122.00USD
0.00USD
Access this data via the Eulerpool API

Zynex Stock analysis

What does Zynex do? Zynex Inc is an American company that manufactures and distributes medical devices and accessories. The company was founded in 1996 and is headquartered in Englewood, Colorado. In recent years, it has become a major player in the pain therapy market. The history of Zynex began with the development of a neurotherapeutic system called NeuroMove, which aimed to restore mobility in patients with paralysis after strokes or other neurological disorders. The company uses proprietary technology to provide safe and effective electrotherapeutic stimulation, which helps trigger muscle contractions and improve mobility. Over the years, the company has specialized in the development and sale of medical devices for pain therapy and rehabilitation. Zynex's products can be used in various areas, including electrostimulation, TENS and EMS therapy, home diagnostics, as well as blood pressure and oxygen measurement. Zynex offers devices specifically for pain therapy. These devices are used by many doctors and physiotherapists to support patients in their healing process. The company's flagship product is the Nexus D-11 EMS and TENS device, which is capable of conducting multiple pain treatments simultaneously. Another important device from Zynex is the InWave system, which applies FDA-approved electromagnetic wave therapy. The therapy is used for both acute and chronic pain and aims to promote the body's natural healing processes to relieve pain. Zynex also manufactures home diagnostic devices such as the blood sugar monitor and pulse oximeter, which can be regularly used by patients at home to monitor their well-being. These products help individuals develop an understanding of how their body responds to different treatments or environmental conditions. An important aspect of Zynex's business model is collaborating with healthcare customers. The company forms partnerships with medical facilities and practitioners to ensure that its products are effectively and safely utilized. These partnerships often include training programs to ensure that users of each device develop a basic understanding of how it works to ensure quality treatment. Zynex has also established a subsidiary called Zynex Medical Europe, which operates in European regions. The company is based in the Netherlands and is responsible for marketing and distributing Zynex's products in Europe. Overall, Zynex has established itself as a key player in the field of pain therapy and rehabilitation. Through its innovative technology and healthcare partnerships, the company is able to provide the best possible patient care. Zynex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zynex stock

Current Assets of Zynex is 75.18 M USD in 2026.

Current Assets of Zynex changed from 87.85 M USD to 75.18 M USD, representing a -14.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Zynex since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Zynex historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Zynex

All Key Metrics — Zynex